Mauritius vs Norway: The number of people with susceptibility test result for rifampicin
Mauritius
83
in 2021
Norway
69
in 2021
Mauritius rank
112th
Norway rank
114th
The number of people with susceptibility test result for rifampicin over time
- Mauritius
- Norway
How they compare
Mauritius currently reports 83 against 69 in Norway, a difference of 14.
That makes Mauritius's figure about 1.2 times Norway's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Norway ahead.
Mauritius ranks 112th and Norway ranks 114th of 155 countries.
Mauritius has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mauritius | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 111 | 105.33 | 5.67 | Mauritius |
| 2020s | 83 | 75 | 8 | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mauritius or Norway?
- Mauritius, at 83 against 69 in Norway as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mauritius and Norway?
- 14, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Norway?
- 5 years are reported by both, from 2017 to 2021.
- How do Mauritius and Norway rank globally for the number of people with susceptibility test result for rifampicin?
- Mauritius ranks 112th and Norway ranks 114th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.